Advances in biological therapies for dyslipidemias and atherosclerosis

This article focuses on the latest developments, clinical potential and current challenges of monoclonal antibodies, vaccines and genome/transcriptome modification strategies, including antisense oligonucleotides, genome/base editing and gene therapy.
Source: Metabolism - Clinical and Experimental - Category: Biomedical Science Authors: Source Type: research